23.44
0.04 (0.17%)
Penutupan Terdahulu | 23.40 |
Buka | 23.86 |
Jumlah Dagangan | 950,823 |
Purata Dagangan (3B) | 1,209,129 |
Modal Pasaran | 1,940,963,328 |
Harga / Jualan (P/S) | 5.49 |
Harga / Buku (P/B) | 2.45 |
Julat 52 Minggu | |
Tarikh Pendapatan | 25 Feb 2025 - 3 Mar 2025 |
Margin Keuntungan | -41.07% |
Margin Operasi (TTM) | -746.40% |
EPS Cair (TTM) | -1.58 |
Pertumbuhan Hasil Suku Tahunan (YOY) | -17.00% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 20.48% |
Nisbah Semasa (MRQ) | 5.69 |
Aliran Tunai Operasi (OCF TTM) | -135.81 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -38.55 M |
Pulangan Atas Aset (ROA TTM) | -9.27% |
Pulangan Atas Ekuiti (ROE TTM) | -18.29% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Biotechnology (US) | Bercampur | Bercampur |
Biotechnology (Global) | Bercampur | Bercampur | |
Stok | Beam Therapeutics Inc. | Menurun | Menurun |
AISkor Stockmoo
Konsensus Penganalisis | 1.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 2.0 |
Purata Bergerak Teknikal | -1.5 |
Osilator Teknikal | -0.5 |
Purata | 0.25 |
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201. |
|
Sektor | Healthcare |
Industri | Biotechnology |
Gaya Pelaburan | Small Value |
% Dimiliki oleh Orang Dalam | 1.48% |
% Dimiliki oleh Institusi | 93.14% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Mwg Management Ltd. | 30 Sep 2024 | 2,266,934 |
Temasek Holdings (Private) Ltd | 30 Sep 2024 | 1,812,972 |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 80.00 (HC Wainwright & Co., 241.30%) | Beli |
Median | 39.00 (66.38%) | |
Rendah | 24.00 (RBC Capital, 2.39%) | Pegang |
Purata | 47.67 (103.37%) | |
Jumlah | 2 Beli, 1 Pegang | |
Harga Purata @ Panggilan | 26.92 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
HC Wainwright & Co. | 09 Dec 2024 | 80.00 (241.30%) | Beli | 27.52 |
07 Nov 2024 | 80.00 (241.30%) | Beli | 26.10 | |
Leerink Partners | 06 Nov 2024 | 39.00 (66.38%) | Beli | 26.62 |
RBC Capital | 06 Nov 2024 | 24.00 (2.39%) | Pegang | 26.62 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |